Waltham, MA, November 1, 2023 – In a move that signifies a robust commitment to refined leadership and strategic market expansion, Voiant, the epitome of excellence in clinical trial imaging solutions, is thrilled to announce the latest addition to its team with the appointment of Stephane Deleger as Chief Commercial Officer. Stephane brings over 25 years of industry experience in commercial development, leading and evolving high-performing sales and marketing teams. In his role as Chief Commercial Officer, Stephane will spearhead global commercial development, propelling Voiant’s growth through targeted market acquisition and strategic customer alliances. Voiant’s CEO, Jim Primerano, expressed his enthusiasm, “Stephane brings to our team a proven track record in driving growth through sales leadership and strategic market development. His unique background and ability for positioning scientific solutions through technology-enabled services will be pivotal as Voiant embarks on our next stage of development and growth.”
Voiant is the industry leading AI-based clinical trial imaging solution provider with unparalleled scientific and clinical domain expertise, providing biopharmaceutical companies with high-speed delivery of quality clinical endpoint data. With a dedicated team of over 200 employees worldwide, Voiant operates offices across Massachusetts, California, New York, India, Europe, and China.